mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
增强移动医疗
基本信息
- 批准号:9974313
- 负责人:
- 金额:$ 72.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcademyAdministratorAdoptionAdultAlcohol or Other Drugs useBackCaliforniaCar PhoneCaringChronicClinicClinicalCognitiveCost Effectiveness AnalysisCritiquesDataDrug ControlsDrug MonitoringDrug RecallsDrug usageDrug userEffectivenessEffectiveness of InterventionsElementsFederally Qualified Health CenterFeedbackFibrinogenFutureGoalsHealthInformal Social ControlInsurance CarriersInterventionIntervention TrialLegalLow incomeMeasuresMedicineMental HealthMethodsMonitorMotivationOutcomePainPatient CarePatient MonitoringPatient PreferencesPatient Self-ReportPatientsPatternPharmaceutical PreparationsPilot ProjectsPoliciesPrevention educationPrevention strategyPrimary Health CareProblem SolvingProviderPsychological reinforcementPublic HealthQualitative ResearchQuality of lifeRandomizedRecommendationResearchRewardsRiskSelf ManagementSelf-CorrectionSingle-Blind StudySubgroupSubstance Use DisorderSymptomsTablet ComputerTechniquesTechnologyTelephoneTestingText MessagingTimeTimeLineUrineUse EffectivenessValidationVisitVoiceWorkaddictionarmbasebehavioral healthcare providerscomorbiditycomparative cost effectivenesscostcost effectivecost effectivenesscravingdashboarddemographicsdesigndrug testingeffectiveness implementation studyethnic minority populationfollow-uphealth service useillicit drug useimplementation researchimprovedmHealthmarijuana usemedical specialtiesmobile applicationmotivational enhancement therapynovelopioid epidemicopioid overdoseparitypatient orientedpatient screeningphysical conditioningpreferencepreventprimary care settingprimary outcomeprogramsresponsescale upscreening and brief interventionsecondary outcomesubstance use preventiontheoriesthree-arm studytooltreatment as usualtrial comparinguptake
项目摘要
PROJECT SUMMARY. The QUIT-Mobile study proposes to use mobile phone self-monitoring and feedback
to enhance and sustain over 12-months the impacts of the Quit Using Drugs Intervention Trial (QUIT), an ef-
fective screening and brief intervention (SBI) previously successful in reducing risky drug use (i.e., moderate
use) in low-income, diverse patients over a 3-month follow up. We propose to conduct the QUIT-Mobile study
for primary care patients who receive care in 8 clinics of federally qualified health centers (FQHC) in Southern
California over 12-months follow up, comparing to QUIT and Usual Care (UC). The proposed study is an Effec-
tiveness-Implementation Hybrid Type 1 design consisting of a single-blind, 3-arm, RCT with adult, mostly La-
tino FQHC primary care patients with risky drug use (ASSIST score 4-26), randomized to 3 conditions
(n=320/arm, n=960 total): 1) QUIT-Mobile; 2) standard QUIT; 3) Usual Care. Qualitative data on implementa-
tion facilitators and barriers will inform future scale-up and sustainability, in addition to cost data and cost-effec-
tiveness analysis. The aims are to examine effectiveness in reducing risky drug use and cost-effectiveness
comparing the three arms over 3-, 6- and 12-months. Drug use measures include urine drug tests, and timeline
follow-back self-reports for past 7-days and past 30-days (risky drug users have sporadic drug use patterns
requiring longer self-report recalls for drug use that urine screens may not detect). The 3-arm study enables
testing of the independent and synergistic effects of QUIT-Mobile compared to QUIT and both to Usual Care,
acknowledging that mHealth components alone may not be effective outside of a clinical/coaching relationship.
The 12-month timeline reflects anticipated scale-up scenarios of annual primary care visits when screening
and brief intervention would be repeated routinely. QUIT contains 3 components: 1) patient screening with the
WHO ASSIST, 2) brief clinician advice (<4 minutes) including opioid overdose prevention education, and 3) 2-
and 6-week telephone drug-use health coaching sessions utilizing motivational interviewing and cognitive be-
havioral techniques, delivered by paraprofessional health coaches. QUIT-Mobile proposes to test the addition
of mobile phone self-monitoring, feedback, and coach monitoring dashboard to enhance and sustain QUIT's
drug use reductions using mobile app, text-messaging (SMS), or interactive voice response (IVR) to allow par-
ticipation by with varying technological preferences. This study does not test which technology platform is more
effective, but rather, the effectiveness of the intervention functions (i.e., self-monitoring, automated feedback,
coach monitoring) that are delivered via patients' preferred technologies. This study is novel and timely in inte-
grating massively scalable mobile phone tools into an effective primary care BI to prevent substance use disor-
der (SUD) in FQHC patients delivered by paraprofessionals. QUIT-Mobile is responsive to the National Opioid
Crisis, and the US Mental Health Parity Act and National Academy of Medicine recommendations to integrate
behavioral health SBIs into primary care settings to prevent higher level SUD requiring specialty treatment.
项目摘要。戒烟的研究建议使用手机自我监控和反馈
为了增强和维持超过12个月的超过12个月的影响,使用药物干预试验(QUIT),EF-
以前成功降低风险使用药物的效力筛查和简短干预(SBI)(即中等)
使用)在低收入中,在3个月的随访中,多样化的患者。我们建议进行戒烟研究
对于在南部联邦资格卫生中心(FQHC)的8个诊所接受护理的初级保健患者而言
加利福尼亚州超过12个月的随访,与戒烟和通常的护理(UC)相比。拟议的研究是一种效率
能阻量实施杂种1型设计,由成人的单盲,3臂,RCT组成,主要是LA-
Tino FQHC初级保健患者患有风险的药物使用(辅助评分4-26),随机分为3个条件
(n = 320/臂,n = 960总计):1)退出摩托车; 2)标准退出; 3)通常的护理。有关实施的定性数据 -
除成本数据和成本效益外,促进者和障碍还将为未来的扩大和可持续性提供信息
能力分析。目的是检查降低危险的药物使用和成本效益的有效性
比较3个,6个月和12个月以上的三个臂。药物使用措施包括尿液药物测试和时间表
跟随过去7天和过去30天的自我报告(风险的吸毒者有零星的药物使用方式
需要更长的自我报告召回尿液筛查可能无法检测到的毒品使用)。 3臂研究启用
与戒烟相比,对退出摩托车的独立和协同作用的测试以及均与通常的护理相比
承认仅在临床/教练关系之外,仅凭MHealth组件可能不会有效。
12个月的时间表反映了筛查时年度初级保健访问的预期缩放情况
简短的干预将定期重复。退出包含3个组成部分:1)患者筛查
谁协助,2)简短的临床医生建议(<4分钟),包括阿片类药物过量预防教育,3)2-
利用动机访谈和认知能力的6周电话药物使用毒品使用健康教练会议
由专业人士健康教练提供的避免技术。退出摩托车建议测试加法
手机自我监控,反馈和教练监视仪表板以增强和维持戒烟
使用移动应用程序,文本消息(SMS)或交互式语音响应(IVR)减少药物使用量,以允许使用
通过不同的技术偏好来进行调整。这项研究没有测试哪个技术平台更多
有效,而是干预功能的有效性(即自我监控,自动反馈,
通过患者首选技术提供的教练监测)。这项研究是新颖的,并且及时
将大规模可扩展的手机工具用于有效的初级保健BI,以防止使用物质使用 -
由专业人士分娩的FQHC患者中的DER(SUD)。退出摩托车对国家阿片类药物有反应
危机以及美国心理健康奇偶校法案和国家医学学院的建议
行为健康SBI进入初级保健环境,以防止需要专业治疗的更高水平的SUD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lillian Gelberg其他文献
Lillian Gelberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lillian Gelberg', 18)}}的其他基金
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
增强移动医疗
- 批准号:
10381700 - 财政年份:2020
- 资助金额:
$ 72.39万 - 项目类别:
mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care
增强移动医疗
- 批准号:
10594011 - 财政年份:2020
- 资助金额:
$ 72.39万 - 项目类别:
Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults
针对 HCV 阳性无家可归成年人制定基于社区的 HCV 治疗完成干预措施
- 批准号:
10022164 - 财政年份:2019
- 资助金额:
$ 72.39万 - 项目类别:
Preventing Drug Use in Low Income Clinic Populations
预防低收入诊所人群吸毒
- 批准号:
7682911 - 财政年份:2008
- 资助金额:
$ 72.39万 - 项目类别:
Preventing Drug Use in Low Income Clinic Populations
预防低收入诊所人群吸毒
- 批准号:
7923181 - 财政年份:2008
- 资助金额:
$ 72.39万 - 项目类别:
Preventing Drug Use in Low Income Clinic Populations
预防低收入诊所人群吸毒
- 批准号:
7533523 - 财政年份:2008
- 资助金额:
$ 72.39万 - 项目类别:
Preventing Drug Use in Low Income Clinic Populations
预防低收入诊所人群吸毒
- 批准号:
8271935 - 财政年份:2008
- 资助金额:
$ 72.39万 - 项目类别:
Preventing Drug Use in Low Income Clinic Populations
预防低收入诊所人群吸毒
- 批准号:
8082126 - 财政年份:2008
- 资助金额:
$ 72.39万 - 项目类别:
Improving Health Habits in Impoverished Populations
改善贫困人口的健康习惯
- 批准号:
7469479 - 财政年份:2007
- 资助金额:
$ 72.39万 - 项目类别:
Improving Health Habits in Impoverished Populations
改善贫困人口的健康习惯
- 批准号:
7210908 - 财政年份:2007
- 资助金额:
$ 72.39万 - 项目类别:
相似海外基金
Consultative Physical Therapy: A Physical Activity and Exercise Implementation Strategy in Parkinson's
咨询物理治疗:帕金森病的身体活动和锻炼实施策略
- 批准号:
10565287 - 财政年份:2023
- 资助金额:
$ 72.39万 - 项目类别:
Improving alcohol and substance use care access, outcomes, and equity during the reproductive years: A Type 1 Hybrid Trial in Family Planning Clinics
改善育龄期酒精和药物滥用护理的获取、结果和公平性:计划生育诊所的 1 类混合试验
- 批准号:
10706526 - 财政年份:2022
- 资助金额:
$ 72.39万 - 项目类别:
Scaling-Up Integrative Pain Management in Federally Qualified Health Centers
在联邦合格的健康中心扩大综合疼痛管理
- 批准号:
10449763 - 财政年份:2022
- 资助金额:
$ 72.39万 - 项目类别:
Scaling-Up Integrative Pain Management in Federally Qualified Health Centers
在联邦合格的健康中心扩大综合疼痛管理
- 批准号:
10667465 - 财政年份:2022
- 资助金额:
$ 72.39万 - 项目类别:
Implementing sexual orientation and gender identity data collection in the electronic medical record within diverse cancer care settings
在不同癌症护理环境中的电子病历中实施性取向和性别认同数据收集
- 批准号:
10640725 - 财政年份:2022
- 资助金额:
$ 72.39万 - 项目类别: